Podofilox
Podofilox Price range: $ 25,00 through $ 112,00
Back to products
Propranolol SR
Propranolol SR Price range: $ 39,00 through $ 136,00

Progesterone

Price range: $ 32,00 through $ 104,00

Progesterone is a vital hormone supplement designed to support reproductive health and maintain natural hormonal balance. It is primarily indicated for use in hormone replacement therapy to protect the uterine lining in postmenopausal women. This medication also plays a crucial role in regulating the menstrual cycle for individuals experiencing secondary amenorrhea. Additionally, certain formulations are used to provide essential luteal support during the early stages of pregnancy. By replenishing necessary hormone levels, this treatment effectively addresses various conditions caused by progesterone deficiency.

Active substance: Progesterone
SKU: Progesterone Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Progesterone belongs to a class of medications known as progestins, which are synthetically derived or micronized forms of the naturally occurring female steroid hormone. In the United States, progesterone formulations are classified as prescription-only (Rx) medications regulated by the FDA for specific endocrine and reproductive indications. This agent plays a critical role in regulating the endometrial lining, supporting pregnancy maintenance, and balancing estrogen levels during hormone replacement therapy.

Available in various pharmaceutical forms including oral micronized capsules, vaginal inserts, gels, and intramuscular injections, progesterone must be administered under direct medical supervision. Proper usage depends on individual clinical parameters, therapeutic goals, and careful assessment of potential contraindications and patient history.

Parameter Details
Active ingredient (INN) Progesterone
Therapeutic class Progestins (AHFS 68:32)
Dosage form Oral capsules (micronized), vaginal gel, vaginal inserts, intramuscular solution
Route of administration Oral, Vaginal, Intramuscular
Primary purpose Endometrial protection, treatment of secondary amenorrhea, reproductive support
Prescription status Prescription only (Rx)
Storage Controlled room temperature 68°F to 77°F (20°C to 25°C)

Clinical and Pharmacological Profile

Mechanism and Indications

How the drug works

Progesterone binds to specific nuclear progesterone receptors located within target tissues, including the uterus, mammary glands, and anterior pituitary gland. Upon binding, the progesterone-receptor complex interacts with genomic DNA to regulate transcription of specific proteins. In the endometrium, progesterone transforms an estrogen-primed proliferative endometrium into a secretory endometrium, preparing the uterine lining for potential embryo implantation. If pregnancy does not occur, a decline in progesterone levels triggers menstrual shedding. Additionally, exogenous progesterone exerts feedback inhibition on the hypothalamic-pituitary axis, suppressing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This inhibition helps prevent estrogen-induced endometrial hyperplasia in postmenopausal individuals undergoing estrogen replacement therapy.

What it’s used for

FDA-approved indications for oral micronized progesterone include the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogen tablets, as well as the treatment of secondary amenorrhea. Specific vaginal formulations carry FDA approval for use in assisted reproductive technology (ART) procedures to support luteal function and early embryo implantation. Off-label indications–which represent clinical uses not explicitly approved by the FDA but prescribed based on clinical judgment–include off-label luteal phase support in non-ART fertility protocols, off-label management of recurrent pregnancy loss linked to documented luteal phase deficiency, and off-label treatment of dysfunctional uterine bleeding.

Dosing schedule

Dosage regimens vary substantially based on the clinical indication, patient age, route of administration, and concurrent therapies. For the prevention of endometrial hyperplasia, oral micronized progesterone is commonly prescribed at a dose of 200 mg daily taken at bedtime for 12 consecutive days per 28-day cycle. For secondary amenorrhea, standard oral dosing often consists of 400 mg daily administered at bedtime for 10 days. Vaginal gels and inserts follow distinct schedule parameters determined by reproductive care specialists. Dosing must be tailored to the individual, and patients should strictly follow the schedule established by their prescribing healthcare provider.

Pharmacokinetics and Drug Interactions

What happens in the body

Oral micronized progesterone is absorbed through the gastrointestinal tract. Particle micronization enhances dissolution and intestinal absorption compared to un-micronized forms. Peak plasma concentrations are generally achieved within 1 to 3 hours following oral ingestion. Progesterone undergoes extensive hepatic first-pass metabolism, converting into active and inactive metabolites, including 5-alpha and 5-beta pregnanes and pregnanediol. Serum progesterone is highly bound to plasma proteins, predominantly albumin and corticosteroid-binding globulin (CBG). Biotransformation occurs mainly in the liver, and elimination occurs primarily via the kidneys as glucuronide-conjugated metabolites, with a smaller portion excreted through biliary routes.

Compatibility with other medicines

Progesterone undergoes hepatic metabolism mediated predominantly by the cytochrome P450 enzyme system, specifically the CYP3A4 isoenzyme. Concomitant administration of strong CYP3A4 inducers–such as rifampin, carbamazepine, St. John’s wort, and phenytoin–can increase the rate of progesterone clearance, resulting in reduced plasma concentrations and diminished therapeutic efficacy. Conversely, potent CYP3A4 inhibitors, including ketoconazole, clarithromycin, and itraconazole, may inhibit progesterone breakdown, elevating serum levels and increasing the risk of adverse reactions. Patients should inform their clinician of all prescription drugs, over-the-counter products, and herbal supplements currently taken.

What to avoid while taking it

Food significantly alters the bioavailability of oral micronized progesterone. Co-administration with food, particularly high-fat meals, increases peak serum concentrations and total exposure. To maintain consistent absorption, oral progesterone should be taken systematically relative to food intake as advised by the prescriber. Alcohol consumption should be restricted or avoided, as alcohol can potentiate the central nervous system depressant effects of progesterone, increasing dizziness and somnolence.

Safety, Administration, and Guidance

Safety Profile and Warnings

Adverse reactions

Common side effects associated with progesterone include central nervous system effects such as somnolence (sedation), dizziness, headache, and mood alterations. Gastrointestinal symptoms may include nausea, abdominal pain, cramping, and bloating. Breast tenderness and musculoskeletal pain are also reported. Vaginal administration routes may cause localized irritation, vaginal discharge, or pelvic discomfort. Serious adverse events, though less frequent, include thromboembolic disorders (such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction), hepatic dysfunction, severe depression, and anaphylactic reactions. Immediate medical evaluation is required if signs of vascular occlusion, severe chest pain, or anaphylaxis occur.

Important precautions

Progesterone is contraindicated in individuals with active or historical arterial or venous thromboembolic disease, severe hepatic impairment or disease, known or suspected breast or genital malignancies, undiagnosed abnormal genital bleeding, or missed abortion. Caution should be exercised in patients with medical conditions sensitive to fluid retention, including asthma, epilepsy, cardiac dysfunction, renal impairment, or severe migraines. Progesterone passes into human breast milk; administration to nursing mothers requires careful evaluation. The safety and effectiveness of progesterone in pediatric populations have not been established.

Daily Use and Management

If you skip a dose

If a dose of progesterone is missed, it should be taken as soon as remembered on the same day, provided it does not closely precede the next scheduled dose. Patients should never double a dose to compensate for a missed application. If multiple doses are missed, the patient should contact their prescribing provider or pharmacist for guidance, as therapy interruptions may induce breakthrough bleeding or alter therapeutic outcomes, particularly in reproductive care cycles.

Practical tips

Because oral micronized progesterone frequently induces drowsiness and mild dizziness due to its neurosteroid metabolites, doses are typically scheduled at bedtime. Patients should refrain from driving, operating heavy machinery, or performing tasks requiring high alertness immediately after taking an oral dose. For vaginal formulations, using a panty liner can help manage routine residue, and remaining recumbent for 15 to 30 minutes following administration can assist optimal local distribution depending on specific formulation instructions.

Storage and expiration

Progesterone preparations must be stored at controlled room temperature, generally between 68°F and 77°F (20°C to 25°C), with brief excursions allowed between 59°F and 86°F (15°C to 30°C). Keep the medication protected from excessive heat, light, and direct moisture. Store oral capsules and vaginal preparations in their original child-resistant containers. Avoid storing medications in humid environments like bathroom cabinets. Expired or unneeded medications should be disposed of in accordance with federal and local state regulations or via community pharmacy take-back initiatives.

Common questions

Why is oral progesterone usually taken at bedtime?

Oral micronized progesterone is metabolized into neurosteroid compounds that cross the blood-brain barrier and produce mild sedative effects. Taking the medication at bedtime minimizes daytime sleepiness and takes advantage of these somnolent properties to improve sleep comfort.

How does food impact oral progesterone absorption?

Ingesting oral progesterone alongside meals, especially high-fat meals, substantially increases its absorption into the bloodstream. This can lead to higher blood concentrations and increased side effects like dizziness. Patients should follow consistent administration habits relative to food as directed by their physician.

What should be done if breakthrough bleeding occurs?

Breakthrough bleeding or spotting can occur during progesterone therapy, particularly during the initial cycles of treatment. If unexpected bleeding persists, worsens, or occurs in postmenopausal women, it should be evaluated by a healthcare professional to rule out underlying endometrial pathology.

Can progesterone interact with herbal supplements?

Yes. Herbal supplements that induce hepatic enzymes, such as St. John’s wort, can accelerate the metabolism of progesterone. This interaction may lower progesterone concentration in the body and reduce its effectiveness. Always inform your provider before starting any herbal products.

Is it safe to drive after taking micronized progesterone capsules?

Because oral progesterone can cause marked somnolence and dizziness, patients should avoid driving or operating dangerous machinery until they understand how the medication affects their alertness and motor coordination.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

200 mg

Package

30 caps

,

60 caps

,

90 caps

,

120 caps

Ενεργός Ουσία